Akorn Files for Chapter 11 After Failed Takeover
The generic drugmaker listed $10 billion of debt and $10 billion of assets.
SEC Charges Drug Firm with Reg FD Violations
In calls and emails, TherapeuticsMD shared material, nonpublic information about a new drug's likelihood of FDA approval with sell-side analysts.
Big Health Care Companies Are Undervalued
McKesson and Walgreens are strong, healthy companies, despite recent downturns in their stock prices, a CEO in the investment field says.
Is Not Telling the ‘Whole Truth’ Securities Fraud?
A jury verdict that held an ex-CFO liable for misleading investors makes clear that the SEC will take action against incomplete disclosures.
Biotech CFO Accused of Misleading Investors
The ex-CFO of Aveo Pharmaceuticals and other top executives allegedly failed to disclose FDA concerns about an experimental cancer drug.
Health Care: Things are Looking App
Mobile health apps are becoming more capable and potentially rather useful.
Taxing Their Patience
The Affordable Care Act's medical-device tax and a proposed Internet sales tax could rile CFOs in 2014.
The Best Medicines
Merck invests billions in drug R&spamp;D every year, and it&spamp;rsquo;s up to CFO Peter Kellogg to ensure that the money is spent wisely.